Aberdeen Group plc Buys 1,496 Shares of Mettler-Toledo International, Inc. $MTD

Aberdeen Group plc boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 9.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,910 shares of the medical instruments supplier’s stock after purchasing an additional 1,496 shares during the period. Aberdeen Group plc’s holdings in Mettler-Toledo International were worth $21,039,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MTD. L. Roy Papp & Associates LLP increased its holdings in Mettler-Toledo International by 3.6% during the second quarter. L. Roy Papp & Associates LLP now owns 10,242 shares of the medical instruments supplier’s stock valued at $12,031,000 after buying an additional 359 shares during the last quarter. IFP Advisors Inc increased its holdings in Mettler-Toledo International by 542.9% during the second quarter. IFP Advisors Inc now owns 90 shares of the medical instruments supplier’s stock valued at $106,000 after buying an additional 76 shares during the last quarter. Callan Family Office LLC increased its holdings in Mettler-Toledo International by 306.5% during the second quarter. Callan Family Office LLC now owns 813 shares of the medical instruments supplier’s stock valued at $955,000 after buying an additional 613 shares during the last quarter. Blair William & Co. IL increased its holdings in Mettler-Toledo International by 17.4% during the second quarter. Blair William & Co. IL now owns 897 shares of the medical instruments supplier’s stock valued at $1,054,000 after buying an additional 133 shares during the last quarter. Finally, Vontobel Holding Ltd. increased its holdings in Mettler-Toledo International by 31.7% during the second quarter. Vontobel Holding Ltd. now owns 494 shares of the medical instruments supplier’s stock valued at $580,000 after buying an additional 119 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on MTD shares. JPMorgan Chase & Co. upped their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Citigroup increased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Finally, Bank of America increased their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $1,336.50.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,289.13 on Tuesday. The firm has a fifty day moving average price of $1,280.14 and a 200 day moving average price of $1,190.80. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,486.76. The firm has a market cap of $26.56 billion, a price-to-earnings ratio of 32.64, a P/E/G ratio of 3.82 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business earned $9.65 earnings per share. Mettler-Toledo International’s quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock worth $2,371,208 over the last 90 days. 0.77% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.